Scripps scientists developed a therapeutic potential of human antibody against cocaine. A stripped-down version of GNCgzk antibody, F(ab’)2-gzk, which contains only the antibody’s cocaine-binding segments significantly reducing coccain overdose signs such as seizures and mortality.
